The Latest from Mayo Clinic Laboratories
As the global reference laboratory for Mayo Clinic, Mayo Clinic Laboratories will help you advance patient care, strengthen your practice, and broaden access to specialized testing. Through our partnerships with clinicians at Mayo Clinic and health care providers around the world, we are able to offer the most sophisticated test catalog in the world. It is because of these daily collaborations that our subspecialized laboratories continue to be a critical component to patient care at Mayo Clinic.
Diagnostic ecosystem boosts access to timely Alzheimer’s disease testingMayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer’s disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The portfolio includes an immunoassay for p-Tau217 that was developed in-house. It also includes C2N Diagnostics’ family of Precivity™ blood tests, which aid the detection of Alzheimer’s pathology in symptomatic patients aged 55 and older. |
The science of diagnosing rare platelet disordersIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Dong Chen, M.D., Ph.D., chair of the Division of Hematopathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic. They discuss rare and inherited platelet disorders and esoteric laboratory testing of hematologic disorders. |
Unique test screens for recently identified peripheral neuropathySorbitol dehydrogenase (SORD) deficiency, recently identified, is a genetic condition that may cause peripheral neuropathy. In this test-specific episode of the “Answers From the Lab” podcast, Matthew Schultz, Ph.D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories’ unique urine assay (Mayo ID: SORD) screens for this rare form of hereditary peripheral neuropathy. |
|
Advancing lupus treatment with modern diagnosticsIn this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guest Donald Thomas, M.D., a rheumatologist and lupus researcher. They discuss how Mayo Clinic Laboratories’ suite of innovative lupus testing, offered in collaboration with Progentec Diagnostics, is enhancing the care and quality of life for patients affected by systemic lupus erythematosus (SLE). |
Education Program
Optimizing cancer care: ASCO guidelines for germline genetic testing
Dec. 12, 2024 | 11 a.m.–Noon CT. This webinar will delve into the latest ASCO guidelines for selection of germline genetic testing panels for cancer patients. Key topics include the importance of taking and recording a detailed family and personal history, selecting the appropriate genes for testing, and determining when and to whom germline testing should be offered. The session will also address the practical implications of the ASCO guidelines, such as balancing the potential benefits of broader gene panel testing with the risks associated with uncertain results. Additionally, participants will gain insights into the specific technical challenges associated with germline genetic testing in cancer care and risk management
How to Order Testing
Many hospitals across the country have already established an account with Mayo Clinic Laboratories. Please click on the links below to register for an account or sign-in.
Registration for an account takes less than 10 minutes, and new accounts are typically processed and available in one business day. Once registered, sign in and locate the test in the Test Catalog and click the “Order This Test” button. Follow the prompts to provide billing and contact information. Print the test requisition form to ship with the specimen.
More from Mayo Clinic Laboratories
Want to read more about what’s happening at our labs? Visit our blog!